Abstract: Managing failover between information handling systems, including receiving, at an interface of a smart network interface card (smartNIC) of a primary information handling system, a packet, the primary information handling system communicatively couped to a secondary information handling system; determining whether the packet was transmitted by a network interface card (NIC) of the secondary information handling system; determining that the packet was transmitted by the NIC of the secondary information handling system, and in response, determining whether the packet is an address resolution protocol (ARP) request; determining that the packet is an ARP request, and in response, cloning a medium access control (MAC) address of the NIC of the secondary information handling system at the smartNIC of the primary information handling system; and forwarding the ARP request to a uplink connection.

Abstract: A method for saving a file stored on a third-party system to a cloud storage system includes receiving, at a cloud storage server of the cloud storage system, a save request from the third party system. The method further includes authenticating the save request, based at least in part on information identifying a user, creating a copy of the file at the cloud storage server, and associating the copy of the file with the user.

Abstract: A multi-functional slurry processing system (“VARCOR”) and associated methods is disclosed. The present examples provide a multi-functional slurry processing system incorporating systems and methods for separating liquid and solid components in slurries. In particular the systems and methods described herein produce clean water, dried solids, and potential concentration of desirable constituents with a boiling point lower than water. At least one example of the multi-functional slurry processing system provides a self-contained processing facility configured to efficiently convert high water-content slurries into its constituent solid and liquid fractions and subsequently generating and collecting clean water and concentrating desirable constituents with a boiling point lower than water.

Abstract: Embodiments of the disclosure include a tissue and/or access device that allows for adjustability of placement of a needle for accessing a blood vessel of an individual in need thereof, particularly when used with an imaging device. The adjustability originates from both angle of the needle for insertion into the body of the individual and longitudinal placement of the needle on the body of the individual. In specific embodiments, a needle guide through which the needle traverses is detachable.

Abstract: Isopropylidenediphenol-based polyether polyols, processes for their production, foams produced using such isopropylidenediphenol-based polyether polyols, such as PUR-PIR rigid foams, as well as to processes for producing such foams. The polyether polyols have an internal block comprising polymerized ethylene oxide moieties and an external cap comprising polymerized propylene oxide moieties.

Abstract: Disclosed herein are glass pharmaceutical vials having sidewalls of reduced thickness. In embodiments, the glass pharmaceutical vial may include a glass body comprising a sidewall enclosing an interior volume. An outer diameter D of the glass body is equal to a diameter di of a glass vial of size X as defined by ISO 8362-1, wherein X is one of 2R, 3R, 4R, 6R, 8R, 10R, 15R, 20R, 25R, 30R, 50R, and 100R as defined by ISO 8362-1. However, the sidewall of the glass pharmaceutical vial comprises an average wall thickness Ti that is less than or equal to 0.85*s1, wherein s1 is a wall thickness of the glass vial of size X as defined by ISO 8362-1 and X is one of 2R, 3R, 4R, 6R, 8R, 10R, 15R, 20R, 25R, 30R, 50R, and 100R as defined by ISO 8362-1.

Abstract: A mobile cleaning robot system can include a mobile cleaning robot and processing circuitry. The mobile cleaning robot can include a camera and can be operable to clean a floor surface of an environment. The processing circuitry can be in communication with the mobile cleaning robot and the camera, the processing circuitry configured to produce an image output based on an optical field of view of the camera. The processing circuitry can also detect a visual fiducial in the image output and can determine a behavior modification based on the visual fiducial. The processing circuitry can modify movement of the mobile cleaning robot based on the behavior modification.

Abstract: The present application relates to triterpene glycoside saponin-derived adjuvants, syntheses thereof, and intermediates thereto. The application also provides pharmaceutical compositions comprising compounds of the present invention and methods of using said compounds or compositions in the treatment of and immunization for infectious diseases.

Abstract: A cloud-based system and method for securely storing data formed into cloud technology-specific data objects (hereinafter, “buckets”) by an S3 gateway, comprising obtaining a source data bucket from the S3 gateway; splitting the data bucket into at least three fragments; encrypting the fragments using an encryption key associated with the fragments and distributing the encrypted fragments among at least three cloud storage providers, and creating a pointer file containing information for retrieving the encrypted fragments. When a system user requests access to the data, the system ensures the request is legitimate, then uses the information stored in the pointer file to retrieve the stored encrypted bucket fragments from the plurality of clouds, decrypts the fragments and reconstructs the data buckets, and provides data access to the S3 gateway.

Abstract: Disclosed is a method of presenting a media file enabling a user to emulate musical content therein. The media file comprises a plurality of segments, each segment representing a demonstration of at least part of a musical phrase comprising one or more musical notes of a piece of music. The method comprises presenting a first segment of the plurality of segments for emulation by the user. The method further comprises subsequently presenting the first segment followed by a second segment of the plurality of segments for emulation by the user. The method further comprises subsequently presenting the previously presented segments followed by additional segments until all of the plurality of segments have been presented for emulation by the user.

Abstract: Disclosed herein are glass pharmaceutical vials having sidewalls of reduced thickness. In embodiments, the glass pharmaceutical vial may include a glass body comprising a sidewall enclosing an interior volume. An outer diameter D of the glass body is equal to a diameter d1 of a glass vial of size X as defined by ISO 8362-1, wherein X is one of 2R, 3R, 4R, 6R, 8R, 10R, 15R, 20R, 25R, 30R, 50R, and 100R as defined by ISO 8362-1. However, the sidewall of the glass pharmaceutical vial comprises an average wall thickness Ti that is less than or equal to 0.85*s1, wherein s1 is a wall thickness of the glass vial of size X as defined by ISO 8362-1 and X is one of 2R, 3R, 4R, 6R, 8R, 10R, 15R, 20R, 25R, 30R, 50R, and 100R as defined by ISO 8362-1.

Abstract: Disclosed herein are glass pharmaceutical vials having sidewalls of reduced thickness. In embodiments, the glass pharmaceutical vial may include a glass body comprising a sidewall enclosing an interior volume. An outer diameter D of the glass body is equal to a diameter d1 of a glass vial of size X as defined by ISO 8362-1, wherein X is one of 2R, 3R, 4R, 6R, 8R, 10R, 15R, 20R, 25R, 30R, 50R, and 100R as defined by ISO 8362-1. However, the sidewall of the glass pharmaceutical vial comprises an average wall thickness Ti that is less than or equal to 0.85*s1, wherein s1 is a wall thickness of the glass vial of size X as defined by ISO 8362-1 and X is one of 2R, 3R, 4R, 6R, 8R, 10R, 15R, 20R, 25R, 30R, 50R, and 100R as defined by ISO 8362-1.

Abstract: A glass cartridge comprises a cylindrical body portion comprising an outer diameter Dc and an average sidewall thickness Tc, the cylindrical body portion having a first end and a second end opposite the first end; an opening at the first end of the cylindrical body portion; a shoulder extending radially inward from the second end of the cylindrical body portion; and a neck extending from the shoulder and comprising an outer neck diameter NOD that is less than the outer diameter Dc of the cylindrical body portion. The average wall thickness Tc is less than or equal to 0.85*s1, wherein s1 is a wall thickness of a standard glass cartridge defined by ISO 13926-1:2004 having an outer diameter d1 that is closer to the outer diameter Dc than the outer diameter d1 of any other standard glass cartridge defined by ISO 13926-1:2004.

Abstract: A circumferential nerve cutter is described herein. The nerve cutter holds a nerve in tension while circumferentially constraining the side of the nerve being retained in a manner that prevents flattening or crushing. A head of the nerve cutter separates the preserved side from the portion of the nerve being cut that is being removed. The head includes a cutting slot configured to accommodate an off-the-shelf scalpel blade, while ensuring that the blade remains approximately square preventing obliquity of resultant cut. The side of the head that interfaces with the preserved side of the nerve is configured to prevent and/or inhibit the nerve from moving radially to its axis while being cut.

Abstract: The present application relates to triterpene glycoside saponin-derived adjuvants, syntheses thereof, and intermediates thereto. The application also provides pharmaceutical compositions comprising compounds of the present invention and methods of using said compounds or compositions in the treatment of and immunization for infectious diseases.

Abstract: A method for manufacturing a biological field-effect transistor (BioFET) is disclosed. In some implementations, the method may include preparing a carbonaceous dispersion by adding a three-dimensional (3D) graphene into a solvent; depositing the carbonaceous dispersion onto a p-type silicon wafer; spin-coating a positive photoresist over the carbonaceous dispersion; forming source and drain terminals on the p-type silicon wafer, the source and drain terminals in contact with the 3D graphene of the carbonaceous dispersion; removing residual photoresist from the carbonaceous dispersion by placing the p-type silicon wafer in 1-methyl-2-pyrrolidone (NMP); and biofunctionalizing the carbonaceous dispersion with a molecular recognition element configured to alter one or more electrical properties of the Bio-FET in response to exposure of the molecular recognition element to the analyte.

Abstract: Disclosed herein are glass pharmaceutical vials having sidewalls of reduced thickness. In embodiments, the glass pharmaceutical vial may include a glass body comprising a sidewall enclosing an interior volume. An outer diameter D of the glass body is equal to a diameter d1 of a glass vial of size X as defined by ISO 8362-1, wherein X is one of 2R, 3R, 4R, 6R, 8R, 10R, 15R, 20R, 25R, 30R, 50R, and 100R as defined by ISO 8362-1. However, the sidewall of the glass pharmaceutical vial comprises an average wall thickness Ti that is less than or equal to 0.85*s1, wherein s1 is a wall thickness of the glass vial of size X as defined by ISO 8362-1 and X is one of 2R, 3R, 4R, 6R, 8R, 10R, 15R, 20R, 25R, 30R, 50R, and 100R as defined by ISO 8362-1.

Abstract: Disclosed herein are glass pharmaceutical vials having sidewalls of reduced thickness. In embodiments, the glass pharmaceutical vial may include a glass body comprising a sidewall enclosing an interior volume. An outer diameter D of the glass body is equal to a diameter d1 of a glass vial of size X as defined by ISO 8362-1, wherein X is one of 2R, 3R, 4R, 6R, 8R, 10R, 15R, 20R, 25R, 30R, 50R, and 100R as defined by ISO 8362-1. However, the sidewall of the glass pharmaceutical vial comprises an average wall thickness Ti that is less than or equal to 0.85*s1, wherein s1 is a wall thickness of the glass vial of size X as defined by ISO 8362-1 and X is one of 2R, 3R, 4R, 6R, 8R, 10R, 15R, 20R, 25R, 30R, 50R, and 100R as defined by ISO 8362-1.

Abstract: This invention provides new products, kits comprising the products, methods for treating conditions using the products, and methods for manufacturing the products. The products comprise an extract, a substrate, and/or a dressing. The extract may comprise a bivalve extract and/or an echinoderm extract.